#mrtx

[ustribunenews-blog]

Hitting 52 Week High, Mirati Therapeutics Inc (Nasdaq:MRTX) Settle At $62.25

Hitting 52 Week High, Mirati Therapeutics Inc (Nasdaq:MRTX) Settle At $62.25

Mirati Therapeutics Inc (Nasdaq:MRTX)

July 27th, 2018

Amidst falling markets Mirati Therapeutics Inc went up $0.40 Friday, a 0.65% increase, closing at $62.25. Furthermore it hit a new 52 week high of $64.15. The stock continues to trade well at 1,299% of its 52 week low of $4.45. Mirati Therapeutics Inc bounced 7.72% between high and low. (more…)

View On WordPress

[ustribunenews-blog]

Setting 52 Week High, Mirati Therapeutics Inc (Nasdaq:MRTX) Close At $55.05

Setting 52 Week High, Mirati Therapeutics Inc (Nasdaq:MRTX) Close At $55.05

Mirati Therapeutics Inc (Nasdaq:MRTX)

July 20th, 2018

Amidst falling markets Mirati Therapeutics Inc closed Friday up 7.94%, a $4.05 increase to close on $55.05. Furthermore it hit a new 52 week high of $58.28. The stock continues to trade well at 1,137% of its 52 week low of $4.45. Mirati Therapeutics Inc swung 14.50% between low and high. In addition to finishing higher, trading volumes were…

View On WordPress

[ustribunenews-blog]

Hitting 52 Week High, Mirati Therapeutics Inc (Nasdaq:MRTX) Ends The Day At $51.50

Hitting 52 Week High, Mirati Therapeutics Inc (Nasdaq:MRTX) Ends The Day At $51.50

Mirati Therapeutics Inc (Nasdaq:MRTX)

June 20th, 2018

Mirati Therapeutics Inc finished up $1.05 Wednesday which equals a 2.08% increase, closing at $51.50. In addition it hit a new 52 week high of $52.95. The stock continues to trade well at 1,561% of its 52 week low of $3.10.

MRTX outperformed the rest of the Healthcare sector which went up 0.20% today.

Expectations from 7 analysts…

View On WordPress

[ustribunenews-blog]

(Nasdaq:MRTX) Mirati Therapeutics, Inc. Sets 52 Week High Bar Of $50.75

(Nasdaq:MRTX) Mirati Therapeutics, Inc. Sets 52 Week High Bar Of $50.75

Mirati Therapeutics, Inc. (Nasdaq:MRTX)

June 14th, 2018

Mirati Therapeutics, Inc. finished up $1.20 Thursday which equals a 2.49% increase, closing at $49.40. In addition it hit a new 52 week high of $50.75. The stock continues to trade well at 1,547% of its 52 week low of $3.00.

MRTX outperformed the rest of the Healthcare sector which went up 0.47% today.

Expectations from 7 analysts…

View On WordPress

[ustribunenews-blog]

Mirati Therapeutics, Inc. (Nasdaq:MRTX) Sets 52 Week High Record Of $48.84

Mirati Therapeutics, Inc. (Nasdaq:MRTX) Sets 52 Week High Record Of $48.84

Mirati Therapeutics, Inc. (Nasdaq:MRTX)

June 13th, 2018

Amidst falling markets Mirati Therapeutics, Inc. closed Wednesday up 3.99%, a $1.85 increase to close on $48.20. In addition it hit a new 52 week high of $48.84. The stock continues to trade well at 1,507% of its 52 week low of $3.00.

MRTX outperformed the rest of the Healthcare sector which went down 0.03% today.

Analysis results…

View On WordPress

[ustribunenews-blog]

Hitting A New 52 Week High, Mirati Therapeutics, Inc. (Nasdaq:MRTX) Close At $44.35

Hitting A New 52 Week High, Mirati Therapeutics, Inc. (Nasdaq:MRTX) Close At $44.35

Mirati Therapeutics, Inc. (Nasdaq:MRTX)

May 26th, 2018

Mirati Therapeutics, Inc. finished up $5.30 Friday, up 13.57%, closing at $44.35. In addition it hit a new 52 week high of $44.55. The stock continues to trade well at 1,543% of its 52 week low of $2.70. In addition to finishing higher, trading volumes were solid at 473% of normal which can indicate investors see opportunities.

MRTX…

View On WordPress

[davidrussellschilling]

About Mirati Therapeutics, Inc.

About Mirati Therapeutics, Inc.

C O N T E N T S:

KEY TOPICS

SAN DIEGO, June 5, 2016 /PRNewswire/ — Mirati Therapeutics, Inc. (NASDAQ: MRTX ) today provided an update on three current ongoing clinical programs in patients with non-small cell lung cancer (NSCLC) and other solid tumors.(More…)

TAMPA, Fla. and SAN DIEGO, June 2, 2016 /PRNewswire/ HedgePath Pharmaceuticals, Inc. (OTCQB: HPPI), a clinical stage biopharmaceutical…

View On WordPress